Latest Articles

Publication Date
Use of the vessel sealer in paraaortic lymphadenectomy in the robotic assisted approach in endometrial cancer - Nature.com

Use of the vessel sealer in paraaortic lymphadenectomy in the robotic assisted approach in endometrial cancer Nature.com

Published: March 10, 2025, 4:20 a.m.
Lymphedema Risk After Sentinel Node Mapping in Endometrial Cancer - Physician's Weekly

Lymphedema Risk After Sentinel Node Mapping in Endometrial Cancer Physician's Weekly

Published: March 7, 2025, 8:30 a.m.
Newly discovered biomarkers could improve endometrial cancer treatment - MSN

Newly discovered biomarkers could improve endometrial cancer treatment MSN

Published: March 6, 2025, 7:35 p.m.
Conference MDAngle: SGO 2025 Endometrial Cancer - Medscape

Conference MDAngle: SGO 2025 Endometrial Cancer Medscape

Published: March 6, 2025, 6:04 p.m.
SGO 2025: Previewing Advancements in Endometrial Cancer - Medscape

SGO 2025: Previewing Advancements in Endometrial Cancer Medscape

Published: March 6, 2025, 5:55 p.m.
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive

Published: March 6, 2025, 2:32 p.m.
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis - Cureus

The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis Cureus

Published: March 6, 2025, 1:45 a.m.
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive

Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer OncLive

Published: March 5, 2025, 8:17 p.m.
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today

ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer Medpage Today

Published: March 5, 2025, 4:47 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!